Virbac SA (VIRP.PA) — Quality & forensics
As of 2026-10-30 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 60
- Quality 53
- Growth 34
- Balance sheet 64
- Cash quality 48
- Capital allocation 36
- Momentum 51
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the VIRP.PA chart & overview
FAQ · from the current data · as of 2026-10-30
Quick answers
What is Virbac SA's Closelooknet quality reading?
The composite reads 50/100 across 7 modules, as of 2026-10-30: valuation 60, quality 53, growth 34, balance sheet 64, cash quality 48, capital allocation 36, momentum 51. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Virbac SA's Altman Z-Score?
3.65, which sits in the safe zone (above 2.99) as of 2026-10-30. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Virbac SA's Piotroski F-Score?
7 of 9, as of 2026-10-30. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Virbac SA's Beneish M-Score indicate?
-2.04 — below the −1.78 manipulation-risk threshold, as of 2026-10-30. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- AMGN Amgen Incindustry
- NVO Novo Nordisk A/Sindustry
- GILD Gilead Sciences Incindustry
- BIIB Biogen Incindustry
- ABBV AbbVie Incindustry
- PFE Pfizer Incindustry
- SNY Sanofi ADRindustry
- JNJ Johnson & Johnsonindustry
- MRK Merck & Company Incindustry
- OGN Organon & Coindustry
- BMY Bristol-Myers Squibb Companyindustry
- 002422.SHE Sichuan Kelun Pharmaceutical Co Ltdindustry
- AZN AstraZeneca PLCindustry
- CMHC.SW COSMO N NVindustry
- EL.PA EssilorLuxottica S. A.sector
- ABVX.PA Abivax SAsector